about
PML regulates p53 stability by sequestering Mdm2 to the nucleolusPML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTORAnalysis of poly(ADP-ribose) glycohydrolase activity in nuclear extracts from mammalian cellsMyb-binding protein 1A (MYBBP1A) is essential for early embryonic development, controls cell cycle and mitosis, and acts as a tumor suppressorRole of PML and the PML-nuclear body in the control of programmed cell deathPML regulates apoptosis at endoplasmic reticulum by modulating calcium releaseRole of nucleophosmin in embryonic development and tumorigenesisHIF factors cooperate with PML-RARα to promote acute promyelocytic leukemia progression and relapseHallmarks of triple negative breast cancer emerging at last?Translation-dependent mechanisms lead to PML upregulation and mediate oncogenic K-RAS-induced cellular senescenceCompound In Vivo Inactivation of Pml and p53 Uncovers a Functional Interaction in Angiosarcoma Suppression.Multiparametric staining to identify apoptotic human cells.HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironmentRegulation of apoptosis by PML and the PML-NBs.24-Hydroxycholesterol participates in pancreatic neuroendocrine tumor developmentA Dialog on the First 20 Years of PML Research and the Next 20 Ahead.A genetic platform to model sarcomagenesis from primary adult mesenchymal stem cells.Hypoxia inducible factor-1α regulates a pro-invasive phenotype in acute monocytic leukemiaAbsence of nucleolar disruption after impairment of 40S ribosome biogenesis reveals an rpL11-translation-dependent mechanism of p53 induction.Bone marrow endosteal mesenchymal progenitors depend on HIF factors for maintenance and regulation of hematopoiesis.Apoptosis-prone phenotype of human colon carcinoma cells with a high level amplification of the c-myc gene.Synergistic Leukemia Eradication by Combined Treatment with Retinoic Acid and HIF Inhibition by EZN-2208 (PEG-SN38) in Preclinical Models of PML-RARα and PLZF-RARα-Driven Leukemia.A HIF-1 network reveals characteristics of epithelial-mesenchymal transition in acute promyelocytic leukemia.PML promotes metastasis of triple-negative breast cancer through transcriptional regulation of HIF1A target genes.Reactivating nuclear PTEN to treat CLL.Pml represses tumour progression through inhibition of mTOR.The nucleolus: at the stem of immortality.Mutations of the PML tumor suppressor gene in acute promyelocytic leukemia.Cdc25A stability is controlled by the ubiquitin-proteasome pathway during cell cycle progression and terminal differentiation.Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer.The effect of the chemotherapeutic drug VP-16 on poly(ADP-ribosylation) in apoptotic HeLa cells.The leukemia-associated cytoplasmic nucleophosmin mutant is an oncogene with paradoxical functions: Arf inactivation and induction of cellular senescence.A retinoic acid-dependent stroma-leukemia crosstalk promotes chronic lymphocytic leukemia progression.HIF-α factors as potential therapeutic targets in leukemiaActivation of poly(ADP-ribose)polymerase in apoptotic human cellsInduction of apoptotic cell death by DNA topoisomerase II inhibitorsLysine-Specific Demethylase 1A as a Promising Target in Acute Myeloid LeukemiaA2A-D2 Heteromers on Striatal Astrocytes: Biochemical and Biophysical Evidence
P50
Q24296743-A90399A0-7221-4135-B410-6BC8A3FBFFDAQ24300018-52FC9151-7EAF-4C3E-81ED-478E9117FBEDQ24309657-1A6D0EBA-886E-427B-B6FA-C58F925D4AFBQ27300691-89743EAC-A2E5-4A3D-87AF-AF0576026B9EQ28190331-888F628F-A765-4608-BE50-854DB7C71789Q28508184-44A180E5-5FDE-4D10-A9BE-D60E7DADCDABQ28508184-79F0AD14-7E85-4D0A-AFA4-5B64BD7AC12AQ28591282-C3D8CF46-C506-4874-975E-FB687E42F74FQ33623363-7BBBE47B-44AE-44B8-86E5-FA34C23B51F2Q34008421-B2D5C830-BB69-4C3C-AC50-CEB662A9D065Q36126248-B9BBF907-1400-4B94-BA80-F82D6F50EFFCQ36664989-B1A673E0-C4AB-4D30-96BC-61F87186F7B9Q36871076-ED5D0A23-A784-419D-9EFD-E961C93D6967Q37097867-3C742A74-B04E-4C9E-A753-05361C15B53CQ37302759-178A7817-E2A4-4529-8FBC-EBE0E45E8031Q37346956-13095C1D-CBC7-48A6-B4EB-6FF2D6AFD1E1Q38191626-BAF2C58A-2923-4B33-8A67-E6CF61E681CCQ38917207-8381077C-7779-4B04-8A75-AE6A1BC53201Q39570910-7FFA78E5-5D5F-48E9-B71B-02F0C76FCE32Q39595474-DC49A95D-D7D1-41A3-AF4D-99C6DE7C809AQ40472737-294069DA-B679-474C-87CD-760502778993Q40976644-65869A2A-9772-4508-A52D-AF4CEA3C0202Q40989861-0048038C-BC69-4C22-B317-E8720A1C7D36Q41751946-6F1A41CC-C27C-4602-B3AB-A24D1FE26AE8Q42177054-B2FA0998-BC0D-4B92-849F-1EC3919D4A2CQ42335075-ADE417A6-AFEA-40DD-94B4-CC2BEB2EF0C4Q42774421-661FBC79-C8F5-438C-8D35-64D63B21525AQ44204312-A89E7CA5-D9B7-403A-B369-D5CDE9842C40Q44664031-965F1AFF-6F88-4BA4-9AC6-BF8CC5C925F8Q45094371-3D00D583-BBB4-4ED5-B86C-9598AB6E34EBQ48087617-87875059-821C-45E3-98D3-0DC15BF93E6AQ52515744-66ECFB60-B6C3-4812-88AB-631E4D694CE0Q53332784-9CE0E967-D3F0-46F8-9C1E-F4998361158DQ55261210-66549AFE-AC97-49D6-AD33-33893D11BCE5Q57808003-3ADB2AF1-3046-4182-BDD7-0507478C4E44Q60192925-E9BA8A92-0687-4683-B910-A1C2196962AFQ60192927-937C87F9-B181-4318-BCD6-FA7243C7899BQ90727256-D5FE80AA-B231-4F25-8A9C-3522CD27AF3DQ92163985-655912A6-2DA2-4D68-881B-0F92A9C2BA97
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Rosa Bernardi
@ast
Rosa Bernardi
@en
Rosa Bernardi
@es
Rosa Bernardi
@sl
type
label
Rosa Bernardi
@ast
Rosa Bernardi
@en
Rosa Bernardi
@es
Rosa Bernardi
@sl
prefLabel
Rosa Bernardi
@ast
Rosa Bernardi
@en
Rosa Bernardi
@es
Rosa Bernardi
@sl
P106
P1153
7006109959
P21
P31
P496
0000-0002-3607-6336